California State Teachers Retirement System (CalSTRS)’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
Other funds holding TRDA
BBA
5VM
TCM
MC
VCM
SG
California State Teachers Retirement System (CalSTRS)'s TRDA Position: Q1 2026 in Review
California State Teachers Retirement System (CalSTRS) reduced its Entrada Therapeutics (TRDA) stake by 12% in Q1 2026, selling an estimated $2.44K and leaving 1,540 shares worth $19.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2454.
California State Teachers Retirement System (CalSTRS) first reported a position in TRDA in Q4 2021 and has held it in 16 quarters since. The position peaked at $280K in Q4 2024. 120 funds tracked by Wall St. Rank hold TRDA as of Q1 2026.
- California State Teachers Retirement System (CalSTRS) held 1,540 shares of Entrada Therapeutics worth $19.4K as of Q1 2026.
- California State Teachers Retirement System (CalSTRS) sold 213 Entrada Therapeutics shares in Q1 2026, an estimated $2.44K.
- Entrada Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2454 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in Entrada Therapeutics in Q4 2021 and has held it in 16 quarters since.
- California State Teachers Retirement System (CalSTRS)'s Entrada Therapeutics position peaked at $280K in Q4 2024.
- 120 funds tracked by Wall St. Rank held Entrada Therapeutics as of Q1 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.